Correction of Crb1 mutations
US9708629B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2014 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Jul 18, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0306
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Genetically engineered mice having a corrected Crb1rd8 mutation and methods for correcting the Crb1rd8 mutation to produce the genetically engineered mice are provided according to aspects of the present invention. Kits, expression vectors and fusion proteins according to aspects of the invention are provided for use to produce the genetically engineered mice characterized by a corrected Crb1rd8 mutation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.